M2 PRESSWIRE-September 5, 2019-: Global Regenerative Medicine
(Cell Therapy, Tissue Engineered, Gene Therapy) Markets, 2014-2018 & 2019-2024
Loiseau went to Kansas Regenerative Medicine
Center (KRMC) where Dr.
(Headquarters: Ohta-ku, Tokyo, Japan; Chairman & CEO: Fujio Mitarai) Canon Medical Systems Corporation ("Canon Medical"; Headquarters: Tochigi Prefecture, Japan; President: Toshio Takiguchi) and the Center for iPS Cell Research and Application, Kyoto University ("CiRA"; Headquarters: Sakyo-ku, Kyoto, Japan; Director: Shinya Yamanaka) announced today that the parties have agreed to commence joint research from August 1, 2019, with the aim of contributing to the field of regenerative medicine
through the realization of higher-quality induced pluripotent stem (iPS) cells1 for autograft purposes, or "my iPS cells2."
Summary: The growth prospects of regenerative medicine
market holds potential owing to rise in the number of potentially successful clinical trials
During the project, Astellas will access LPIXEL's AI-instilled image analysis solution, IMACEL Lab, for the cell selection and management processes in conducting research on regenerative medicine
and cell therapy.
OTTAWA, Canada, March 20, 2019 -- The Government of Canada has approved a multi-year investment of $18 million in stem cell and regenerative medicine
research through the Stem Cell Network (SCN).
Summary: New Delhi [India], Nov 24 (ANI): The non-surgical and minimally-invasive Stem Cell Technology has emerged as the most promising medical procedure for diseases like diabetes, heart problems and is increasingly being recognized as mainstream medical science, said prominent international and Indian doctors participating in STEMCELL XPRESS, an international conference on Stem Cell, Regenerative Medicine
& Anti-Ageing processes.
The in-person meeting is part of the expedited review process afforded to Capricor for its CAP-1002 product candidate after being granted the regenerative medicine
advanced therapy, or RMAT, designation by the FDA in February.
(OTCQB: MDVX) has agreed to acquire Florida, US-based biomedical services company Regenerative Medicine
Solutions, LLC's pulmonary biomedical services and patient delivery platform (RMS) in an all-stock transaction, the company said.
'Bio Japan 2018', the first exchange meeting between Taiwan and Japan in the field of regenerative medicine
was held on Oct.